---
figid: PMC3545031__nihms425793f2
figtitle: 'Melanoma resistance to photodynamic therapy: new insights'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3545031
filename: nihms425793f2.jpg
figlink: /pmc/articles/PMC3545031/figure/F2/
number: F2
caption: Melanosomes mature through stages 1–4 and are finally transferred to keratinocyes
  where they release melanin granules. Defects in apoptosis (BCL2), BRAF-mutation
  activated MAPK/ERK pathway, and ABC-transporter drug efflux pumps contribute to
  melanoma resistance.
papertitle: 'Melanoma resistance to photodynamic therapy: new insights.'
reftext: Ying-Ying Huang, et al. Biol Chem. ;394(2):239-250.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7589017
figid_alias: PMC3545031__F2
figtype: Figure
redirect_from: /figures/PMC3545031__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3545031__nihms425793f2.html
  '@type': Dataset
  description: Melanosomes mature through stages 1–4 and are finally transferred to
    keratinocyes where they release melanin granules. Defects in apoptosis (BCL2),
    BRAF-mutation activated MAPK/ERK pathway, and ABC-transporter drug efflux pumps
    contribute to melanoma resistance.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - SRPK
  - Debcl
  - KRAS
  - HRAS
  - NRAS
  - BRAF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - ABCB6
  - BCL2
---
